scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
scPharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
scPharmaceuticals reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, three executives at scPharmaceuticals received on average a compensation package of $1.2M, a 21% increase compared to previous year.
Average pay of disclosed executives at scPharmaceuticals
John H. Tucker, Chief Executive Officer, received $1.5M in total, which decreased by 25% compared to 2017. 59% of Tucker's compensation, or $887K, was in option awards. Tucker also received $99K in non-equity incentive plan, $494K in salary, as well as $11K in other compensation.
Abraham Ceesay, Chief Operating Officer, received a compensation package of $1.1M, which increased by 54% compared to previous year. 64% of the compensation package, or $719K, was in option awards.
Troy Ignelzi, Chief Financial Officer, earned $900K in 2018, a 20% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2019.